Why the study?
Can MRI and MRS be used to measure changes in liver fat levels following surgical, lifestyle, or drug treatments in obese, NAFLD, or NASH subjects?
Can MRI and MRS be used to measure changes in liver fat levels following surgical, lifestyle, or drug treatments in obese, NAFLD, or NASH subjects?
Answers are grounded in this paper and cite their sources.
MRI and MRS provide highly reproducible, non-invasive methods to quantify changes in liver fat content in clinical trials for obesity and fatty liver disease.
With an increasing insulin resistance and obesity epidemic, various intervention trials aiming to reduce liver fat levels are using non-invasive MRI methods as alternatives to repeated biopsies to measure the changes in liver fat levels in controlled clinical trials. MRI and MRS exploit differences in the resonance frequencies of signals from protons in fat and water to quantify liver, fat depot and/or muscle fractional fat content in a highly reproducible manner. Various clinical trials have reported the baseline liver fat values and ranges along with the changes in fat levels following different surgical, nutritional, lifestyle or pharmaceutical interventions.
No takes yet. Share an insight, caveat, or question.
Tengowski et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: